John McKendry

Kye is a growth-stage Canadian specialty pharmaceutical company committed to bringing value to Canadians by identifying, licensing and commercializing novel prescription medicines that may not otherwise be available to patients across Canada. At Kye, we recognize the importance of advancing access to innovative healthcare solutions and unlocking better health outcomes for Canadians.